Articles related to Pulmonology

These data suggest that a negative rapid antigen test in individuals with residualsymptoms could provide reassurance about ending isolation.

A comprehensive review on the widespread uptake of vaping, including its origins and history, a timeline of discoveries, terminology, epidemiology, its use as a “harm reducer,” clinical presentations of vaping lung injuries (including an overview of the 2019 EVALI outbreak), the pathophysiology of vaping-induced lung injury, clinical aspects including outcomes, COVID-19 considerations, future directions, guidelines, and questions for future research.

Burkholderia pseudomallei bacteria showed up in four patients in Georgia, Kansas, Minnesota, and Texas in 2021, despite the bacterium typically associated with travel to tropical and subtropical areas like Thailand and Malaysia. The case was cracked when researchers found an essential oil spray that contained B. pseudomallei in the home of a 4-year-old boy who died from complications of the melioidosis outbreak.

Can you determine what the appropriate treatment is for a 65-year-old man is diagnosed with multiple segmental pulmonary emboli?

The FDA has withdrawn its authorization for use of the monoclonal antibody sotrovimab in the treatment of COVID-19 in regions with a high frequency of the Omicron BA.2 subvariant. Data show that the authorized dose of the monoclonal antibody — 500 mg — is unlikely to be effective against the BA.2 COVID-19 subvariant.

In March 2021, the US Preventive Services Task Force expanded the eligibility for lung cancer screening by setting the benchmark at a 20 pack-year smoking history for those ages 50 to 80 years who are current smokers or former smokers who have quit within the past 15 years. The new criteria will boost the number of eligible adults by 87% overall, according to a modeling analysis. It also could reduce lung cancer deaths by 13% versus 10% previously.